Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sobrade is a medical device developed by Pohl-Boskamp for the symptomatic treatment of heartburn and acid reflux. It is formulated as a chewable tablet that, upon mastication, forms a viscous gel complex consisting of carbomer and sodium hyaluronate. This gel adheres to the esophageal mucosa, providing a physical protective barrier against gastric acid and pepsin, thereby facilitating the healing of the irritated lining and providing rapid relief from burning sensations. Unlike systemic antacids, its primary mode of action is mechanical and local, creating a shield that prevents acid from damaging the esophageal tissue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sobrade.